Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
European Journal of Immunology|September 1, 1994
Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeysC J Reist, H Y Liang, D Denny, et al.
Reviews of Infectious Diseases|January 1, 1981
Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivoM A Sande, O M Korzeniowski, G M Allegro, et al.
Infection and Immunity|April 1, 1979
Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitisW M Scheld, T S Park, R G Dacey, et al.
The Journal of Clinical Investigation|August 1, 1980
Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisoloneW M Scheld, R G Dacey, H R Winn, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1983
Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunctionJ C Mihindu, W M Scheld, N D Bolton, et al.
Clinical Therapeutics|April 22, 1999
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study GroupD C Henry, D J Moller, J Adelglass, et al.
The Journal of Infectious Diseases|November 1, 1983
Moxalactam for the treatment of bacterial meningitis in childrenJ M Freedman, S H Hoffman, W M Scheld, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study GroupJ M Gwaltney, S Savolainen, P Rivas, et al.
Infection and Immunity|April 1, 1995
Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1J H Powers, B L Buster, C J Reist, et al.
Clinical Therapeutics|May 1, 1989
Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung diseaseR E McCabe, D Schlossberg, G R Donowitz, et al.
Pageof 16